Pages that link to "Anti-restenotic efficacy of SES is non-superior to PES in patients with SES-restenosis: Results of the ISAR-DESIRE 2 Trial"

Jump to navigation Jump to search
What links here
⧼whatlinkshere-whatlinkshere-target⧽
⧼whatlinkshere-whatlinkshere-ns⧽
⧼whatlinkshere-whatlinkshere-filter⧽

No pages link to Anti-restenotic efficacy of SES is non-superior to PES in patients with SES-restenosis: Results of the ISAR-DESIRE 2 Trial.